Seaport Diagnostics
PrivateLast Round
Series B
Jul 12, 2018
Total Funding Raised
$50M
Company Overview
Seaport Diagnostics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in July 2018.
Seaport Diagnostics is a biotechnology company that develops molecular diagnostic testing and consumer-focused genetic testing kits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Subscription Commerce
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seaport Diagnostics Comparables
Compare Seaport Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SelfDecode | 76% | |
| Everly Health | 76% | |
| LetsGetChecked | 73% |
For institutional investors. Book with your work email.
Seaport Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 12, 2018 | ||||
| Series A Extension | Jun 27, 2017 | ||||
| Series A | Dec 16, 2015 | ||||
| Seed | Feb 5, 2015 |
For institutional investors. Book with your work email.
Seaport Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haitong International Securities Group | Series B |
| Vectr Ventures | Series B |
| Spectrum Health Ventures | Series B, Series A Extension |
| MMIC Investment Holdings, Inc. | Series B |
| Hatteras Venture Partners | Series B, Seed, Series A, Series A Extension |
| KTB Ventures | Seed, Series B |
| Alexandria Venture Investments | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2017
$20M round led by Hatteras Venture Partners.
- Dec 16, 2015
$13M round led by Hatteras Venture Partners and Syno Capital.
For institutional investors. Book with your work email.
Seaport Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Seaport Diagnostics's valuation, stock price, and market status.
Is Seaport Diagnostics a public or private company?
Seaport Diagnostics is a private company.
What is the current stock price of Seaport Diagnostics?
Seaport Diagnostics is a private company, so its shares have no public market price. Caplight tracks Seaport Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Seaport Diagnostics worth (valuation)?
Valuation information for Seaport Diagnostics is not publicly available.
Can I buy Seaport Diagnostics stock?
Seaport Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Seaport Diagnostics's last funding round?
Seaport Diagnostics's most recent funding round was Series B on July 12, 2018.
Who are the main investors in Seaport Diagnostics?
Key investors in Seaport Diagnostics include Haitong International Securities Group, Hatteras Venture Partners, Syno Capital.
Will Seaport Diagnostics IPO soon?
No public IPO plans have been announced for Seaport Diagnostics.
How can I track Seaport Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Seaport Diagnostics's shares on secondary markets.